Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New directions in supportive care.

Steven M Grunberg

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer

|March 12, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC).

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2015

Same author

Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy.

Cancer chemotherapy and pharmacology·2014

Same author

Chemotherapy-induced nausea and vomiting incidence and prevalence.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2014

Same author

Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement.

Breast (Edinburgh, Scotland)·2013

Same author

Emerging treatments in chemotherapy-induced nausea and vomiting.

Clinical advances in hematology & oncology : H&O·2013

Same author

Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics.

Journal of applied physiology (Bethesda, Md. : 1985)·2013

Molecular advances in supportive care enhance symptom management and quality of life. Understanding genetic variations improves treatment efficacy and reduces chemotherapy toxicity.

Area of Science:

Oncology
Molecular Biology
Genetics

Background:

Traditional supportive care focuses on symptom management and quality of life.
Recent molecular biology and genetics advances offer new avenues for supportive care.

Purpose of the Study:

To explore how molecular and genetic advancements can refine supportive care strategies.
To investigate the impact of genetic variations on supportive care agent efficacy and toxicity.

Main Methods:

Analysis of receptor mutations and their effect on antiemetic and analgesic sensitivity.
Investigation of metabolic pathway variations influencing supportive care and chemotherapy outcomes.
Exploration of altered receptor ligands for improved symptom management.
Defining symptoms like fatigue and outlook through enzymatic pathways.

Related Experiment Videos

Main Results:

Receptor mutations can alter patient sensitivity to supportive care medications.
Metabolic pathway variations impact both supportive care agent effectiveness and chemotherapy toxicity.
Altered receptor ligands offer potential for differential effects in symptom management.
Enzymatic pathways provide a molecular basis for understanding symptoms like fatigue.

Conclusions:

Molecular and genetic insights are revolutionizing supportive care.
Personalized approaches based on individual genetic profiles can optimize supportive care.
These advancements promise more effective symptom management and improved patient outcomes in cancer therapy.